Patrick G. Lepore

Insider Reports History

Entity
Individual
Location
17 17 Route 208 N, Fairlawn, NJ
Signature
/s/ Mutya Harsch, attorney-in-fact for Patrick G. LePore
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick G. Lepore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LANNETT CO INC Director Common Stock 587K $476K $0.81 Nov 10, 2022 Direct
VYNE Therapeutics Inc. Director Common Stock 36.5K $83.2K $2.28 Nov 15, 2023 Direct
VYNE Therapeutics Inc. Director Stock Option (right to buy) 20K Jan 1, 2024 Direct

Insider Reports Filed by Patrick G. Lepore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VYNE VYNE Therapeutics Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
VYNE VYNE Therapeutics Inc. Dec 13, 2023 1 $0 4 Dec 15, 2023 Director
VYNE VYNE Therapeutics Inc. Nov 15, 2023 1 $50.8K 4 Nov 17, 2023 Director
VYNE VYNE Therapeutics Inc. Mar 20, 2023 1 $49.7K 4 Mar 22, 2023 Director
LCI LANNETT CO INC Nov 10, 2022 1 $49K 4 Nov 14, 2022 Director
VYNE VYNE Therapeutics Inc. Aug 10, 2022 1 $0 4 Aug 12, 2022 Director
LCI LANNETT CO INC May 16, 2022 1 $27K 4 May 17, 2022 Director
LCI LANNETT CO INC Feb 8, 2022 1 $44K 4 Feb 10, 2022 Director
VYNE VYNE Therapeutics Inc. Nov 30, 2021 1 $12.7K 4 Dec 2, 2021 Director
LCI LANNETT CO INC Nov 29, 2021 1 $85.5K 4 Nov 30, 2021 Director
LCI LANNETT CO INC Sep 8, 2021 1 $66.2K 4 Sep 9, 2021 Director
LCI LANNETT CO INC Aug 31, 2021 1 $0 4 Sep 2, 2021 Director
VYNE VYNE Therapeutics Inc. Aug 25, 2021 1 $20K 4 Aug 26, 2021 Director
VYNE VYNE Therapeutics Inc. Jul 19, 2021 1 $0 4 Jul 20, 2021 Director
VYNE VYNE Therapeutics Inc. May 26, 2021 1 $45K 4 May 27, 2021 Director
LCI LANNETT CO INC May 11, 2021 1 $83.6K 4 May 12, 2021 Director